Drug name - Ofirmev

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9610265 MALLINCKRODT HOSP Reduced dose intravenous acetaminophen Nov, 2028

(6 years from now)

US9987238 MALLINCKRODT HOSP Reduced dose intravenous acetaminophen Nov, 2028

(6 years from now)

US10383834 MALLINCKRODT HOSP Reduced dose intravenous acetaminophen Nov, 2028

(6 years from now)

US9610265

(Pediatric)

MALLINCKRODT HOSP Reduced dose intravenous acetaminophen May, 2029

(6 years from now)

US9987238

(Pediatric)

MALLINCKRODT HOSP Reduced dose intravenous acetaminophen May, 2029

(6 years from now)

US9399012 MALLINCKRODT HOSP Reduced dose intravenous acetaminophen Sep, 2031

(8 years from now)

US9399012

(Pediatric)

MALLINCKRODT HOSP Reduced dose intravenous acetaminophen Mar, 2032

(9 years from now)

Drugs and Companies using ACETAMINOPHEN ingredient

Treatment: Modified dosing regimen for the management of moderate to severe pain with adjunctive opioid analgesics; Modified dosing regimen for the management of mild to moderate pain or management of moderate to severe pain as an adjunct to opioid analgesics; Modified dosing regimen for the reduction of fever; modified dosing regimen for the management of mild to moderate pain; Modified dosing regimen for the reduction of fever; modified dosing regimen for the management of mild to moderate pain or management of moderate to severe pain as an adjunct to opioid analgesics

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
1GM/100ML (10MG/ML) SOLUTION;INTRAVENOUS Discontinued

availability in other generic markets.

Click on the highlighted region to filter.